GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gongwin Biopharm Holdings Co Ltd (ROCO:6617) » Definitions » Net Margin %

Gongwin Biopharm Holdings Co (ROCO:6617) Net Margin % : -381.90% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Gongwin Biopharm Holdings Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Gongwin Biopharm Holdings Co's Net Income for the three months ended in Dec. 2023 was NT$-33.03 Mil. Gongwin Biopharm Holdings Co's Revenue for the three months ended in Dec. 2023 was NT$8.65 Mil. Therefore, Gongwin Biopharm Holdings Co's net margin for the quarter that ended in Dec. 2023 was -381.90%.

The historical rank and industry rank for Gongwin Biopharm Holdings Co's Net Margin % or its related term are showing as below:

ROCO:6617' s Net Margin % Range Over the Past 10 Years
Min: -178624.19   Med: -16997.3   Max: -280.89
Current: -280.89


ROCO:6617's Net Margin % is ranked worse than
57.48% of 1030 companies
in the Biotechnology industry
Industry Median: -157.59 vs ROCO:6617: -280.89

Gongwin Biopharm Holdings Co Net Margin % Historical Data

The historical data trend for Gongwin Biopharm Holdings Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gongwin Biopharm Holdings Co Net Margin % Chart

Gongwin Biopharm Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -44,283.87 -11,173.11 -10,637.01 -22,238.76 -486.58

Gongwin Biopharm Holdings Co Quarterly Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -6,016.19 - -185.07 -381.90

Competitive Comparison of Gongwin Biopharm Holdings Co's Net Margin %

For the Biotechnology subindustry, Gongwin Biopharm Holdings Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gongwin Biopharm Holdings Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gongwin Biopharm Holdings Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Gongwin Biopharm Holdings Co's Net Margin % falls into.



Gongwin Biopharm Holdings Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Gongwin Biopharm Holdings Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-92.037/18.915
=-486.58 %

Gongwin Biopharm Holdings Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-33.027/8.648
=-381.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gongwin Biopharm Holdings Co  (ROCO:6617) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Gongwin Biopharm Holdings Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Gongwin Biopharm Holdings Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gongwin Biopharm Holdings Co (ROCO:6617) Business Description

Traded in Other Exchanges
N/A
Address
3rd Floor, No.80, Jianguo North Road, Section 1, Zongshan District, Taipei, TWN, 10491
Gongwin Biopharm Holdings Co Ltd is a Taiwanese biotech and pharmaceutical company engaged in research and development of anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma.

Gongwin Biopharm Holdings Co (ROCO:6617) Headlines

No Headlines